Cayuga Biotech Information
Contact top employees from
Cayuga Biotech
Summary
The company currently specializes in the Biotechnology area. Its headquarters is located at US. The estimated number of employees - 11. To connect with Cayuga Biotech employee register on SignalHire.
Organization Website | cayugabiotech.com |
Phone Number | 1.917.208.9108 |
Industries | |
Headquarters Location | New York and Massachusetts, US |
Employees Size | 1-10 employees |
Specialties | biotechnology, pharmaceuticals, hematology, coagulation, postpartum hemorrhage, trauma, blood thinner bleeding, surgery, hemophilia, thrombocytopenia, rare bleeding, hemostasis, surgical bleeding, gastrointestinal hemorrhage |
Employees Turnover 4 quarter 2025
Length of Employment
Employee tenure at Cayuga Biotech shows a diverse range of experience levels:
11% have been with the company for less than 1 year22% for 1–2 years11% for 3–4 years11% for 5–7 years33% for 8–10 years11% have over 11 years of service at Cayuga BiotechEx-employees positions
In Company
In New Company
Contact top employees from
Cayuga Biotech
Damien Kudela
Co-Founder and Chief Science Officer
Steve Gormican
Member Board of Directors (Observer)
Andrea Ashford
Chief Executive Officer
Nathan Ogden
Director CMC
Similar Companies
FAQ
Cayuga Biotech operates in the Biotech industries. More details can be found on the official website: cayugabiotech.com.
The headquarters of Cayuga Biotech are located in New York and Massachusetts, United States.
You can contact Cayuga Biotech by phone at 1.917.208.9108.
Cayuga Biotech currently employs 1-10 people.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
